Ted yednock

Company: Annexon Biosciences

Job title: CIO

Seminars:

Lessons Learned from C1q Inhibition in Neurodegenerative Conditions 9:30 am

Understanding the basic scientific mechanism behind C1q inhibition in neurodegenerative diseases Explore how complement’s role in the pathophysiology of neurodegenerative diseases influenced the scientific rationale behind targeting C1q Hear the lessons learned by Annexon in targeting C1q for Guillain-Barré syndrome, Huntington’s Disease and Amyotrophic Lateral SclerosisRead more

day: Conference Day One